SUK MING FUNG: Open Payments
NPI 1598996498 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 11 payments from 6 companies in 2025. Trend: 2023 $963 · 2024 $906 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $110 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $40 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: JARDIANCE, ISTURISA, TERLIVAZ, CAMZYOS, Attruby, LEQVIO.
Industry payments across NY — which companies pay providers there.
